PD-L1, expressed by either malignant cells or tumor-infiltrating DC, has been shown to promote the development, maintenance, and suppressive functions of Tregs in diverse hematologic malignancies such AML [114,125,126]. The gene discussed is CD274; the disease is hematologic disorder.